This assay is intended for in vitro quantitative determination of C-Reactive Protein in human serum, plasma and whole blood. The test kit is used as an aid in the diagnosis of infection and inflammation. For in vitro diagnostic use only. Lyophilized Beads: ● Individual packaging Shelf life: ● Maximum 36 months Storage: ● 2 - 30℃, away from sunlight * No cold chain
This assay is intended for in vitro quantitative determination of Hemoglobin A1c in human whole blood. The test kit is used as an aid to monitor long-term glycemic status in patients with diabetes mellitus. For in vitro diagnostic use only. Shelf life: ● 18 months Storage: ● 2 - 30℃, away from sunlight * No cold chain
This assay is intended for in vitro quantitative determination of Free Thyroxine in human serum and plasma. The test kit is used as an aid in the diagnosis of thyroid disease. For in vitro diagnostic use only. Shelf life: ● 18 months Storage: ● 2 - 30℃, away from sunlight * No cold chain
This assay is intended for in vitro quantitative determination of Free Triiodothyronine in human serum and plasma. The test kit is used as an aid in the diagnosis of thyroid disorders. For in vitro diagnostic use only. Shelf life: ● 18 months Storage: ● 2 - 30℃, away from sunlight * No cold chain
This assay is intended for in vitro quantitative determination of total triiodothyronine (TT3) in human serum and plasma. The test kit is used as an aid in the diagnosis of thyroid disease. For in vitro diagnostic use only. Shelf life: ● 18 months Storage: ● 2 - 30℃, away from sunlight * No cold chain
This assay is intended for in vitro quantitative determination of total thyroxine in human serum and plasma. The test kit is used as an aid in the diagnosis of thyroid disease. For in vitro diagnostic use only. Shelf life: ● 18 months Storage: ● 2 - 30℃, away from sunlight * No cold chain
This assay is intended for in vitro the quantitative determination of Cardiac Troponin T in human serum and plasma.The test kit is used as an aid in the diagnosis of myocardial infarction. For in vitro diagnostic use only. Shelf life: ● 18 months Storage: ● 2 - 30℃, away from sunlight * No cold chain
This assay is intended for in vitro quantitative determination of Cortisol in human serum and plasma. The test kit is used as an aid in the detection of functional disorders of the adrenal gland. For in vitro diagnostic use only. Shelf life: ● 18 months Storage: ● 2 - 30℃, away from sunlight * No cold chain
This assay is intended for in vitro quantitative determination of Estradiol in human serum and plasma. The test kit is used as an aid in the evaluation of ovarian disease. For in vitro diagnostic use only. Shelf life: ● 18 months Storage: ● 2 - 30℃, away from sunlight * No cold chain
About Poclight Nanjing Poclight Biotechnology Co., Ltd. (hereinafter referred to as "Poclight Biotechnology") is an innovative and R&D enterprise focusing on the development of in vitro medical diagnosis (IVD) platform. We have R&D and production site of 5,000 ㎡, including more than 4,800 ㎡ of GMP workshops of 10,000 level and 100,000 level. Relying on the patent platform of "Chemiluminescence Resonance Energy Transfer (CRET)" independently developed by Poclight Biotechnology, our company has developed a number of homogeneous chemiluminescence immunoassay products, covering clinical medicine, animal medicine, drug detection and other fields, with the characteristics of "precision, accuracy, low cost, rapid, small and excellent". Competitive advantage Poclight Biotechnology is fully engaged in the research and development and industrialization of “Chemiluminescence Resonance Energy Transfer” (CRET) technology. Our company has obtained the authorization of this patent, which is the only one in the world. Our company has obvious competitive advantages in the IVD industry, which are mainly reflected in the following aspects: 1、The world's leading 5th generation chemiluminescence technology At the technical level, the fifth generation chemiluminescence immunoassay technology is the world's exclusive, belonging to the underlying technology upgrade, and the company has complete intellectual property rights. 2、Full test items coverage with matching micro chemiluminescence In terms of products, we achieve extremely simplified and unique product design, which not only improves product performance, but also greatly reduces costs, and improves user experience in all links, whether terminal or agent. 3、Traditional POCT technology alternative innovation In terms of market, in the field of animal medicine to fully polish the technology and products; At the same time, the products are extremely compatible with the international market, and the foreign business supports the domestic clinical business to achieve differentiated competition. Domestic clinical business starts from the primary market, realizes the sink of chemiluminescence technology in combination with industrial policies, and then gradually occupies the secondary laboratory, tertiary emergency and bedside testing to realize the replacement of traditional POCT. Finally, it competes for the market share of tertiary laboratory under the industrial background of import substitution. 4、Global top returnee R&D team, super technology R&D strength In terms of talents, the core team is all graduated from famous universities at home and abroad, responsible for R & D, marketing, registration, marketing, production, etc. All come from in vitro diagnosis (IVD) industry, and have an average of more than 8 years of industry experience, team implementation, strong execution, strong technical innovation. Our Sales Region Map
Rich Experience
Global top returnee R&D team, super technology R&D strength.
Employee Award 100+ Total
The best service team, with pre and post sales guarantees and careful guidance.
Professional Manufacturer
More than half of the employees are R&D staff, quality are guaranteed.
Partners Award 200+ Total
Work with a number of hospitals and doctors to get the most accurate data.
The 33rd International Society on Thrombosis and Haemostasis (ISTH 2025) opened in Washington, USA, at 10:00 AM Eastern Time on June 22 (10:00 PM Beijing Time on June 23). Top global experts in thrombosis, hemostasis, and hematology gathered to exchange cutting-edge science, release the latest research findings, and discuss common topics such as new clinical applications and improving patient care. At this grand event, "Chinese Smart Manufacturing" was showcased on the world stage. As the only company in China presenting independently innovative cell testing products, Poclight's platelet activation function detection product based on CRET cell technology received high praise and widespread attention from attending experts, thanks to its unique design concepts and technical highlights. In contrast, traditional testing methods are losing attention to emerging technologies, reflecting the urgent demand for innovative solutions in the field of clinical diagnostics. In the field of platelet function testing, flow cytometry, as a new method, can detect platelet activation functions. However, its technical characteristics lead to complex operations, which cannot guarantee timeliness and also affect the stability of platelets. This results in test results that cannot reflect the true state of platelets in vivo, providing minimal benefit for clinical guidance. Aggregation instruments can only detect platelet aggregation functions, which are greatly influenced by platelet counts, making testing impossible for patients with low platelet counts. Poclight's innovative CRET cytometry combines activation and function testing while achieving POCT capabilities, making it a powerful tool to break through the challenges of timeliness and situational complexity! CRET cytometry perfectly achieves a dual breakthrough in testing efficiency and clinical practicality, turning the industry's dreams into reality and providing new ideas and tools for thrombosis and hemostasis research, showcasing unlimited potential! Poclight's innovative CRET cell technology has achieved a breakthrough: Integrated activation and functional detection Break through the limitation of platelet count Obtain quantitative results in as fast as 5 minutes Truly achieve POCT detectionEasier operation, more real and reliable results